Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis

Mult Scler. 2023 May;29(6):748-752. doi: 10.1177/13524585221150743. Epub 2023 Jan 24.

Abstract

Background: Data on corpus callosum involvement in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are limited.

Objective: The objective of the study was to compare callosal lesions in MOGAD, multiple sclerosis (MS), and aquaporin-4-IgG positive neuromyelitis optica spectrum disorder (AQP4+NMOSD).

Results: Callosal lesion frequency was similar in MOGAD (38/171 (22%)), MS (24/72 (33%)), and AQP4+NMOSD (18/63 (29%)). Clinical phenotypes included encephalopathy (47%) and focal supratentorial (21%) or infratentorial (45%) deficits. None had callosal-disconnection syndromes. Maximal callosal-T2-lesion diameter (median (range)) in millimeter was similar in MOGAD (21 (4-77)) and AQP4+NMOSD (22 (5-49); p = 0.93) but greater than in MS (10.5 (2-64)). Extracallosal extension (21/38 (55%)) and T2-lesion resolution (19/34 (56%)) favored MOGAD.

Conclusions: Despite similar frequency and imaging overlap, larger lesions, sagittal midline involvement, and lesion resolution favored MOGAD.

Keywords: Myelin oligodendrocyte glycoprotein; aquaporin 4; corpus callosum; magnetic resonance imaging; multiple sclerosis; neuromyelitis optica.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aquaporin 4
  • Autoantibodies
  • Corpus Callosum / diagnostic imaging
  • Corpus Callosum / pathology
  • Humans
  • Immunoglobulin G
  • Leukoencephalopathies*
  • Multiple Sclerosis* / diagnostic imaging
  • Myelin-Oligodendrocyte Glycoprotein
  • Neuromyelitis Optica* / diagnostic imaging
  • Neuromyelitis Optica* / pathology

Substances

  • Myelin-Oligodendrocyte Glycoprotein
  • Autoantibodies
  • Aquaporin 4
  • Immunoglobulin G